Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADHD diagnosis through EEG, a pilot study
2006-002716-94Phase 2Completed
- Sponsor
- Mentis Cura
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Mentis Cura. Primary endpoint: EEG measurements in ADHD and healthy boys. Started Aug 2006; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2006-002716-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002716-94.